Systematic identification of genomic markers of drug sensitivity in cancer cells.

Nature 2012 Mar 28;483(7391):570-5. Epub 2012 Mar 28.

Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.

Clinical responses to anticancer therapies are often restricted to a subset of patients. In some cases, mutated cancer genes are potent biomarkers for responses to targeted agents. Here, to uncover new biomarkers of sensitivity and resistance to cancer therapeutics, we screened a panel of several hundred cancer cell lines--which represent much of the tissue-type and genetic diversity of human cancers--with 130 drugs under clinical and preclinical investigation. In aggregate, we found that mutated cancer genes were associated with cellular response to most currently available cancer drugs. Classic oncogene addiction paradigms were modified by additional tissue-specific or expression biomarkers, and some frequently mutated genes were associated with sensitivity to a broad range of therapeutic agents. Unexpected relationships were revealed, including the marked sensitivity of Ewing's sarcoma cells harbouring the EWS (also known as EWSR1)-FLI1 gene translocation to poly(ADP-ribose) polymerase (PARP) inhibitors. By linking drug activity to the functional complexity of cancer genomes, systematic pharmacogenomic profiling in cancer cell lines provides a powerful biomarker discovery platform to guide rational cancer therapeutic strategies.

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature11005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349233PMC
March 2012
59 Reads

Publication Analysis

Top Keywords

cancer
9
cancer genes
8
cancer cell
8
genes associated
8
mutated cancer
8
mutated genes
4
associated sensitivity
4
frequently mutated
4
tissue-specific expression
4
expression biomarkers
4
biomarkers frequently
4
sensitivity broad
4
range therapeutic
4
relationships revealed
4
revealed including
4
unexpected relationships
4
agents unexpected
4
additional tissue-specific
4
therapeutic agents
4
broad range
4

References

(Supplied by CrossRef)

BJ Druker et al.
N. Engl. J. Med. 2006

EL Kwak et al.
N. Engl. J. Med. 2010

PB Chapman et al.
N. Engl. J. Med. 2011

U McDermott et al.
J. Clin. Oncol. 2009

RH Shoemaker et al.
Prog. Clin. Biol. Res. 1988

JN Weinstein et al.
Science 1997

U McDermott et al.
Proc. Natl Acad. Sci. USA 2007

N Suwaki et al.
Sci. Transl. Med. 2011

L Deng et al.
Cancer Biol. Ther. 2010

DM Weber et al.
N. Engl. J. Med. 2007

GE Konecny et al.
Cancer Res. 2006

Similar Publications